Project Grant R01GM155900
Award Date
7/15/24
Completion Date
5/31/28
Dollars Obligated
$316K
Federal Agency
National Institute of General Medical Sciences
Federal Grant Program
93.859
Assistance Type
Project Grant
Place of Performance
Ithaca, NY 14853, USA
Similar Awards
This Project Grant awarded by the National Science Foundation (NSF) under the Mathematical and Physical Sciences (CFDA 47.049) program provides $418,579 to Cornell University to develop a new class of bioconjugates to improve the intracellular delivery of peptide-based proteolysis targeting chimeras (PEPTACs) for proteome-editing applications. The key objectives are to study the impact of conjugation site on antibody-PEPTAC conjugate (APC) transport and the release kinetics of PEPTAC-cell...
The National Institute of General Medical Sciences (NIGMS) awarded a $148,568 Project Grant to Cornell University under the Biomedical Research and Research Training Program (CFDA 93.859) to identify and characterize a novel family of GTPase Activating Proteins (GAPs). The primary objectives are to: 1) Determine the target GTPase substrates and subcellular localization of these novel GAPs, and 2) Investigate the structure and enzymatic function of the GAPs to understand how they regulate...
This federal Project Grant award of $1,203,701.00 from the National Institute of General Medical Sciences (NIGMS) Biomedical Research and Research Training Program (CFDA 93.859) supports a research program aimed at improving drug development processes. The program has three main focus areas: Developing ATP-allosteric bivalent inhibitors (AABIs) to selectively target the inactive state of human protein kinases, enabling rapid identification of promising new drug targets. This includes tailoring...
This Project Grant award for $380,540, awarded by the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training Program (CFDA 93.859), supports research to decipher novel principles of rapid proteostatic control and develop spatiotemporal lysosomal tools. The research aims to define new protein substrates and peptide motifs required for lysosomal delivery, determine the functional impact of methyl-driven lysosomal proteolysis on cellular metabolic...
This Project Grant award from the National Institute of General Medical Sciences (NIGMS) Biomedical Research and Research Training Program (CFDA 93.859) is supporting research to develop a DNA-based protein degradation system and delivery platform. The goal is to pioneer the next generation of targeted protein degradation (TPD) technologies. The $940,288 award to Arizona State University (ASU) aims to: Optimize the programmability of a DNA-based protein degradation system by transitioning from...
This federal Project Grant award of $440,000 from the National Institute of General Medical Sciences (NIGMS) Biomedical Research and Research Training Program (CFDA 93.859) supports a research program at the Sloan-Kettering Institute for Cancer Research focused on decoding the ubiquitin and autophagy signaling networks involved in proteome homeostasis, an essential cellular process. The research aims to uncover novel aspects of ubiquitin regulation and explore the mechanisms underlying selective...
This $1,215,158 Project Grant award from the National Institute of General Medical Sciences (NIGMS) Biomedical Research and Research Training Program (CFDA 93.859) will support Cornell University's research program to deconvolve the language of protein binding. The research aims to identify the rules and mechanisms governing how transcription factors bind to the human genome, including the effects of epigenetic state and cellular co-factors on binding specificity. Key objectives include using...
This federal Project Grant award from the National Institute of General Medical Sciences (NIGMS), under the Biomedical Research and Research Training Program (CFDA 93.859), totaling $1,207,500.00, supports Duke University's research to develop programmable, isoform-selective proteome editing systems. The project aims to expand upon the university's existing work on peptide-guided enzymes for post-translational protein modifications, enabling both protein degradation and stabilization. Key...
The federal Project Grant award of $627,797 from the National Institute of General Medical Sciences (NIGMS) Biomedical Research and Research Training Program (CFDA 93.859) aims to delineate the molecular mechanisms connecting endocytic and junctional complexes with epithelial pathology in C. elegans. The research program uses a multi-disciplinary approach combining genetic screens, live imaging, biochemical assays, and structural biology to investigate how membrane-associated protein complexes...
This federal Project Grant award, R35GM156858, was provided by the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training Program (CFDA 93.859). The grant will support research to characterize the molecular mechanisms and evolution of cyclic diguanylic acid (c-di-GMP) signaling in the antibiotic-producing bacterial genus Streptomyces. Key focus areas include: (1) understanding how c-di-GMP regulates the developmental life cycle in the model...